Unknown

Dataset Information

0

Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX).


ABSTRACT:

Background

Because circulating antibodies against a variety of antigens have been detected in patients with coronary heart disease, carotid atherosclerosis and those who have suffered a stroke, it is suspected that immune response may be one of the mechanisms of atherogenesis The objective of this study is to identify novel antibodies in ischemic stroke patients by screening the expressed recombinant proteins using a human cDNA library (SEREX).

Methods

To identify the candidate antigens, cDNA library was screened by SEREX using plasma from ten patients with ischemic stroke. Subsequently, via ELISA using recombinant proteins and synthetic peptides, the serum antibody levels were measured in two independent patient/healthy donor (HD) cohorts (142 and 78 in the 2nd screening and a validation cohort, respectively).

Results

The initial screening resulted in the identification of six candidate antigens. Of these antigens, replication protein A2 (RPA2) was determined to be the antigen associated with stroke (P < 0.05) by ELISA with 2nd screening and validation cohort. Multifactorial logistic regression analysis showed that the increased levels of the RPA2 antibodies (RPA2-Abs) associated with stroke independent of other risk factors for stroke (P < 0.05). Receiver operating curve analysis demonstrated that the area under the curve from ELISA using GST fusion RPA2 and synthetic peptides (bRPA2-132) were 0.867 (95% CI: 0.798-0.936) and 0.971 (95% CI: 0.940-1.00), respectively. If the cut-off value of the bRPA2-132-Ab level was determined to be 0.334, the sensitivity and specificity of the antibody level as the diagnostic marker for stroke were 0.323 (95% CI: 0.209-0.453) and 1.00 (95% CI: 0.713-1.00), respectively.

Conclusions

SEREX identified RPA2 as the antigen associated with ischemic stroke and serum auto-antibodies against RPA2 elevates in stroke patients. RPA2-Abs could become a biomarker for the evaluation of ischemic stroke at risk.

SUBMITTER: Machida T 

PROVIDER: S-EPMC4344740 | biostudies-literature | 2015 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Identification of stroke-associated-antigens via screening of recombinant proteins from the human expression cDNA library (SEREX).

Machida Toshio T   Kubota Motoo M   Kobayashi Eiichi E   Iwadate Yasuo Y   Saeki Naokatsu N   Yamaura Akira A   Nomura Fumio F   Takiguchi Masaki M   Hiwasa Takaki T  

Journal of translational medicine 20150222


<h4>Background</h4>Because circulating antibodies against a variety of antigens have been detected in patients with coronary heart disease, carotid atherosclerosis and those who have suffered a stroke, it is suspected that immune response may be one of the mechanisms of atherogenesis The objective of this study is to identify novel antibodies in ischemic stroke patients by screening the expressed recombinant proteins using a human cDNA library (SEREX).<h4>Methods</h4>To identify the candidate an  ...[more]

Similar Datasets

| S-EPMC5915093 | biostudies-literature
| S-EPMC2995456 | biostudies-literature
| S-EPMC3161784 | biostudies-literature
| S-EPMC3906402 | biostudies-literature
| S-EPMC5322808 | biostudies-literature
| S-EPMC2957082 | biostudies-literature
| S-EPMC22686 | biostudies-literature
| S-EPMC3066439 | biostudies-literature
2020-08-28 | GSE152785 | GEO
| S-EPMC42453 | biostudies-other